AUSTRALIA

Ashley I. Bush, M.D., Ph.D.
The Mental Health Research Institute of Victoria
Parkville, Australia
Modulation of Toxic Beta-Amyloid Species by Novel Therapeutics
Investigator-Initiated Research Grant—$235,188 over three years

Gerard J. Byrne, M.B.B.S., Ph.D.
University of Queensland
Herston, Australia
Synaptic Dysfunction in Alzheimer's Disease
Investigator-Initiated Research Grant—$238,013 over three years

CANADA

Karl Fernandes, Ph.D.
Université de Montréal
Montréal, Québec
Canada
Stimulation of neural precursors in transgenic mouse models of Alzheimer's
New Investigator Research Grant--$100,000 over two years

Isabelle Aubert, Ph.D.
Sunnybrook Health Sciences Centre
Toronto, Ontario
Canada
Novel Approaches to Generate Cholinergic Neurons from Progenitor Cells
Investigator-Initiated Research Grant—$240,000 over three years

Shernaz X. Bamji, Ph.D.
University of British Columbia
Vancouver, British Columbia
Canada
Beta-Catenin Stabilization in the Synaptic Pathology of Alzheimer's Disease
New Investigator Research Grant—$99,252 over two years

Heather Carnahan, Ph.D.
Toronto Rehabilitation Institute
Toronto, Ontario
Canada
The Application of a Tactile Way-Finding Belt to Facilitate Navigation
Everyday Technology for Alzheimer’s Care—$155,408 over two years

Margaret Fahnestock, Ph.D.
McMaster University
Hamilton, Ontario
Canada
Mechanism of Decreased BDNF in Alzheimer's Disease Brain 
Investigator-Initiated Research Grant—$240,000 over three years

John G. Sled, Ph.D.
The Hospital for Sick Children
Toronto, Ontario
Canada
Relating Vascular Pathology to Memory Deficits in APP Overexpressing Mice
Investigator-Initiated Research Grant—$198,390 over two years

ITALY

Daniela Puzzo, M.D., Ph.D.
University of Catania
Catania, Italy
Functional Role of Beta-Amyloid in Synaptic Plasticity and Memory
New Investigator Research Grant—$99,880 over two years

THE NETHERLANDS

Bart Van Berckel, M.D.
VU University Medical Centre
Amsterdam, Netherlands
Assessment of Blood-Brain Barrier Integrity in Alzheimer’s Disease
New Investigator Research Grant—$100,000 over two years

SINGAPORE

Philip Yap, M.R.C.P.
Alexandra Hospital
Singapore, Singapore
Continence Management for Dementia Patients Through Wetness Alert Diaper
Everyday Technology for Alzheimer’s Care—$106,500 over three years

UNITED KINGDOM

Jesse Hoey, Ph.D.
University of Dundee
Dundee, United Kingdom
Development of an Automated System to Facilitate Creative Expression
Everyday Technology for Alzheimer’s Care—$199,650 over three years

UNITED STATES

Arizona

Rena Li, M.D., Ph.D.
Sun Health Research Institute
Sun City, Arizona
Studies on Estrogen and DNA Repair in a APP Transgenic Mouse Model
Investigator-Initiated Research Grant—$239,966 over three years

Yong Shen, M.D., Ph.D.
Sun Health Research Institute
Sun City, Arizona
Elevated BACE1 as a Risk Factor for Progression from Mild Cognitive Impairment to Alzheimer’s Disease
Zenith Fellows Award—$250,000 over three years

California

Michel Baudry, Ph.D.
University of Southern California
Los Angeles, California
SOD/Catalase Mimetics for the Treatment of Alzheimer's Disease
Investigator-Initiated Research Grant—$240,000 over three years

Gal Bitan, Ph.D.
University of California, Los Angeles
Los Angeles, California
Investigation of Beta-Amyloid Protein Oligomerization and Neurotoxicity
Investigator-Initiated Research Grant—$240,000 over three years

Anahit Ghochikyan, Ph.D.
The Institute for Molecular Medicine
Huntington Beach, California
Testing of Alzheimer’s Disease DNA Vaccine: Protective Vaccination Versus Therapeutic
Investigator-Initiated Research Grant—$239,220 over three years

Amy Jak, Ph.D.
Veterans Medical Research Foundation
San Diego, California
Activity Levels, Cognition, and Temporal Lobe Integrity in At-Risk Adults
New Investigator Research Grant—$100,000 over two years

Madepalli K. Lakshmana, Ph.D.
University of California, San Diego
La Jolla, California
Role of Novel LRP-Binding Proteins on the Amyloidogenic Processing of APP
New Investigator Research Grant—$100,000 over two years

Po-Haong Lu, Psy.D.
University of California, Los Angeles
Los Angeles, California
Mapping Prospective Changes in Brain and Cognition in Aging and Disease
New Investigator Research Grant—$100,000 over two years

Qiulan Ma, M.D., Ph.D.
Sepulveda Research Corporation
North Hills, California
Mechanisms of PTEN-Signaling Defects in Alzheimer’s Disease
New Investigator Research Grant—$99,980 over two years

Stephen A. O’Barr, Ph.D.
Western University of Health Sciences
Pomona, California
CHP+Zn and T4 Treatment Decreases Beta-Amyloid Levels and Improves Cognition In Vivo
New Investigator Research Grant—$100,000 over two years

Gil D. Rabinovici, M.D.
University of California, San Francisco
San Francisco, California
Amyloid PET Imaging in the Differential Diagnosis of Alzheimer’s Disease and Frontotemporal Lobar Degeneration
New Investigator Research Grant—$100,000 over two years

Steven S. Schreiber, M.D.
University of California, Irvine
Orange, California 
Efficacy of Nicotinamide for the Treatment of Alzheimer's Disease
Investigator-Initiated Research Grant—$239,947 over three years

Karl H. Weisgraber, Ph.D.
The J. David Gladstone Institutes
San Francisco, California
Association of ApoE4 with Alzheimer’s Disease: A New Paradigm
Zenith Fellows Award—$250,000 over two years

Huaxi Xu, Ph.D.
Burnham Institute for Medical Research
La Jolla, California
Characterizing a Novel Gene that Inhibits GSK3 Activity and Beta-Amyloid Generation
Zenith Fellows Award—$250,000 over two years

Colorado

Christopher D. Link, Ph.D.
University of Colorado
Boulder, Colorado
Structure/Function Analysis of In Vivo Beta-Amyloid Peptide Toxicity
Zenith Fellows Award—$249,968 over two years

Connecticut

Christopher H. Van Dyck, M.D.
Yale University
New Haven, Connecticut
Amyloid Binding in Subjects at Risk for Alzheimer’s Disease
Investigator-Initiated Research Grant—$239,967 over three years

Florida

Marcia Gordon, Ph.D.
University of South Florida
Tampa, Florida
Cell-Based Therapies Using Transgenic Mice
Investigator-Initiated Research Grant—$240,000 over three years

Malcolm A. Leissring, Ph.D.
The Scripps Research Institute
Jupiter, Florida
Genetic Modulation of Beta-Amyloid Catabolism
Investigator-Initiated Research Grant—$240,000 over three years

Leonard Petrucelli, Ph.D.
Mayo Clinic Jacksonville
Jacksonville, Florida
CHIP, Molecular Chaperones and Tau Biology
Investigator-Initiated Research Grant—$240,000 over three years

Georgia

Melanie C. Greenaway, Ph.D.
Emory University
Atlanta, Georgia
A Memory Compensation Intervention in Mild Cognitive Impairment
New Investigator Research Grant—$99,544 over two years

Illinois

Lisa L. Barnes, Ph.D.
Rush University Medical Center
Chicago, Illinois
Stress, Inflammatory Markers, and Cognitive Decline in Older Adults
Investigator-Initiated Research Grant—$239,992 over three years

Ken-ichiro Fukuchi, M.D., Ph.D.
University of Illinois – Chicago
Peoria, Illinois 
Vectored Vaccines for Alzheimer’s Disease
Investigator-Initiated Research Grant—$240,000 over three years

Changiz Geula, Ph.D.
Northwestern University
Chicago, Illinois
Calbindin, Aging and Vulnerability of Cholinergic Neurons to Degeneration
Zenith Fellows Award—$249,998 over two years

Orly Lazarov, Ph.D.
University of Illinois – Chicago
Chicago, Illinois
The Effect of Environmental Enrichment on Familial Alzheimer’s Disease-Linked Pathology
New Investigator Research Grant—$100,000 over two years

Kalipada Pahan, Ph.D.
Rush University Medical Center
Chicago, Illinois
Neutral Sphingomyelinase in Beta-Amyloid-Induced Neuronal Death
Investigator-Initiated Research Grant—$239,662 over three years

Indiana

Gregory W. Arling, Ph.D.
Indiana University
Indianapolis, Indiana
Developing Comprehensive Dementia-Specific Nursing Home Quality Indicators
Investigator-Initiated Research Grant—$238,464 over three years

Greg A. Sachs, M.D.
Indiana University
Indianapolis, Indiana
Alzheimer’s Disease and Access to Palliative Care
Investigator-Initiated Research Grant—$193,027 over two years

Joseph Thomas, Ph.D.
Purdue University
West Lafayette, Indiana
Medication Use and Functioning in Patients with Dementia
Investigator-Initiated Research Grant—$237,054 over three years 

Kansas

Sang-Pil Lee, Ph.D.
University of Kansas Medical Center Research Institute, Inc.
Kansas City, Kansas
Quantitative In Vivo Measure of an Alzheimer’s Disease Drug Treatment in Transgenic Mice
New Investigator Research Grant—$100,000 over two years

Patricia Pohl, Ph.D.
University of Kansas Medical Center Research Institute, Inc.
Kansas City, Kansas
Effects of Delivery Mode of Cognitive Intervention in Early Alzheimer’s Disease
Investigator-Initiated Research Grant—$240,000 over three years

Kentucky

Gregory A. Jicha, Ph.D.
University of Kentucky Research Foundation
Lexington, Kentucky
Telemedicine Assessment of Cognition in Rural Kentucky: The TACK Study
New Investigator Research Grant—$99,675 over two years

Maryland

Katherine Conant, M.D.
Johns Hopkins University
Baltimore, Maryland
MMPs and Synaptic Injury in Alzheimer's Disease
Investigator-Initiated Research Grant—$240,000 over three years

Michael K. Lee, Ph.D.
Johns Hopkins University
Baltimore, Maryland
Beta-Amyloid and Monoaminergic Neurodegeneration in Alzheimer’s Disease Transgenic Mice
Investigator-Initiated Research Grant—$240,000 over three years

Veronika A. Szalai, Ph.D.
University of Maryland Baltimore County
Baltimore, Maryland
Neurotoxicity and Structure of Copper-Containing Beta-Amyloid
Investigator-Initiated Research Grant—$239,988 over three years

Massachusetts

Deborah Blacker, M.D., Sc.D.
Massachusetts General Hospital
Charlestown, Massachusetts
Cross Sectional and Longitudinal Analysis of Alzheimer’s Disease Quantitative Phenotypes
Investigator-Initiated Research Grant—$237,893 over three years

Vivian Budnik, Ph.D.
University of Massachusetts
Worcester, Massachusetts
Genetic Strategies to Elucidate APP Function During Synapse Formation
Investigator-Initiated Research Grant—$240,000 over three years

Bradford Dickerson, M.D.
Massachusetts General Hospital
Charlestown, Massachusetts
Ultrahigh-Resolution MRI of Medial Temporal Lobe in Mild Cognitive Impairment: A Pilot Study
New Investigator Research Grant—$100,000 over two years

Xudong Huang, Ph.D.
Brigham and Women's Hospital, Inc.
Boston, Massachusetts
A Novel Metal-Complexing Antioxidant Targeting Alzheimer Amyloid
Investigator-Initiated Research Grant—$240,000 over three years

June Kinoshita, B.A.
Alzheimer’s Research Forum Foundation
Boston, Massachusetts
SWAN: A Community Knowledge Base for Alzheimer’s Disease Research
Investigator-Initiated Research Grant—$239,568 over three years

Henry W. Querfurth, M.D., Ph.D.
Caritas St. Elizabeth's Medical Center
Boston, Massachusetts
Intraneuronal Beta-Amyloid and Synaptic Plasticity in the Prefrontal Cortex
Investigator-Initiated Research Grant—$236,000 over three years

Jie Shen, Ph.D.
Brigham and Women's Hospital, Inc.
Boston, Massachusetts
Mechanisms of Neurodegeneration Caused by Loss of Presenilin Function
Investigator-Initiated Research Grant—$240,000 over three years

Benjamin Wolozin, M.D., Ph.D.
Boston University
Boston, Massachusetts
LRRK2 Interactions with Pathways Linked to Protein Folding and Degradation
Investigator-Initiated Research Grant—$239,999 over three years

Zhongcong Xie, M.D., Ph.D.
Massachusetts General Hospital
Charlestown, Massachusetts
Inhalation Anesthetic Isoflurane and Alzheimer's Disease Neuropathogenesis
Investigator-Initiated Research Grant—$240,000 over three years

Michigan

Elaine K. Hebda-Bauer, Ph.D.
University of Michigan
Ann Arbor, Michigan
How Overexpression of a Stress Gene Modifies Alzheimer’s Disease Pathology
Investigator-Initiated Research Grant—$239,957 over three years

Scott Roberts, Ph.D.
University of Michigan
Ann Arbor, Michigan
Communicating Diagnostic and Risk Information to People with Mild Cognitive Impairment
Investigator-Initiated Research Grant—$239,985 over three years

Carey W. Sherman, Ph.D.
University of Michigan
Ann Arbor, Michigan
Alzheimer Caregiving in the Context of Late-life Remarriage
New Investigator Research Grant—$99,826 over two years

Raymond S. Turner, M.D., Ph.D.
University of Michigan
Ann Arbor, Michigan
Drug-Protein Complexes as Inhibitors of Beta-Amyloid Aggregation
Investigator-Initiated Research Grant—$240,000 over three years

Minnesota

Rosalie A. Kane, Ph.D.
University of Minnesota - Twin Cities
Minneapolis, Minnesota
Small-House Nursing Homes and Alzheimer’s Disease
Investigator-Initiated Research Grant—$239,992 over three years

Missouri

Alison M. Goate, D.Phil.
Washington University in St. Louis
St. Louis, Missouri
Molecular Mechanisms of Neurodegeneration in Frontotemporal Lobar Degeneration
Investigator-Initiated Research Grant—$239,143 over three years

Margaret A. Perkinson, Ph.D.
Saint Louis University
St. Louis, Missouri
Family-Assisted Exercise Programs in a Dementia Care Facility
Investigator-Initiated Research Grant—$199,949 over two years

Harry W. Tyrer, Ph.D.
University of Missouri-Columbia
Columbia, Missouri
A Smart Carpet: Technology for Persons with Alzheimer’s Disease
Everyday Technology for Alzheimer’s Care—$200,000 over three years

Weixiong Zhang, Ph.D.
Washington University in St. Louis
St. Louis, Missouri
Initial Steps Toward Elucidating Gene Expression Regulation of Late-Onset Alzheimer’s Disease
New Investigator Research Grant—$100,000 over two years

New York

Ottavio Arancio, M.D.
Columbia University
New York, New York
CBP Involvement in Alzheimer’s Disease and its Potential Therapeutic Value
Zenith Fellows Award—$250,000 over two years

Miguel A. Gama Sosa, Ph.D.
Mount Sinai School of Medicine
Bronx, New York
Presenilin-1 and Signaling Through the HIF Pathway
Investigator-Initiated Research Grant—$240,000 over three years

Anastasios Georgakopoulos, Ph.D.
Mount Sinai School of Medicine
New York, New York
Role of Presenilin-1/Gamma-Secretase in EphB-Induced Angiogenesis
Investigator-Initiated Research Grant—$240,000 over three years

Jorge A. Ghiso, Ph.D.
New York University
New York, New York
Signature Markers of Beta-Amyloid Degradation
Investigator-Initiated Research Grant—$240,000 over three years

Stephen D. Ginsberg, Ph.D.
The Nathan S. Kline Institute for Psychiatric Research
Orangeburg, New York
Profiling Vulnerable Hippocampal Populations in Mild Cognitive Impairment and Alzheimer’s Disease
Investigator-Initiated Research Grant—$240,000 over three years

Gunnar K. Gouras, M.D.
Joan & Sanford I. Weill Medical College of Cornell University
New York, New York
Mechanism of Beta-Amyloid-Induced Synaptic Dysfunction
Zenith Fellows Award—$250,000 over two years

Edmund C. Jenkins, Ph.D.
Research Foundation for Mental Hygiene, Inc. at NYS Institute for Basic Research
Staten Island, New York
Telomere Shortening in Older Individuals with Down Syndrome and Dementia
Investigator-Initiated Research Grant—$239,939 over three years

Gail V. W. Johnson, Ph.D.
University of Rochester
Rochester, New York
Tau Oligomerization and Aggregation Analysis: A Novel Approach
Investigator-Initiated Research Grant—$239,991 over three years

Voyko Kavcic, Ph.D. 
University of Rochester
Rochester, New York
Multimodal Approach for Early Detection of Alzheimer’s Disease
The Senator Mark Hatfield Award for Clinical Research—$240,000 over three years

Efrat Levy, Ph.D.
The Nathan S. Kline Institute for Psychiatric Research
Orangeburg, New York
Cystatin C-Derived Peptides as Inhibitors of Beta-Amyloid Aggregation
Investigator-Initiated Research Grant—$240,000 over three years

Zaibo Li, M.D., Ph.D.
University of Rochester
Rochester, New York
Beta-Amyloid Elicits its Neurotoxicity by Activating Fyn/c-Cbl Pathway
New Investigator Research Grant—$99,738 over two years

Paul M. Mathews, Ph.D.
New York University
Orangeburg, New York
Neuroprotection Following Modulation of Endogenous Beta-Amyloid in Mice
Investigator-Initiated Research Grant—$240,000 over three years

Giulio M. Pasinetti, M.D., Ph.D.
Mount Sinai School of Medicine
New York, New York
Anti-Hypertensive Drugs that Prevent AD Beta-Amyloid Pathology
Investigator-Initiated Research Grant—$240,000 over three years

Jeremy M. Silverman, Ph.D.
Mount Sinai School of Medicine
New York, New York
A Longitudinal Study of Successful Cognitive Aging Phenotypes in Costa Rica
Investigator-Initiated Research Grant—$240,000 over three years

Yi Wen, Ph.D.
Columbia University
New York, New York
Regulation of APP Processing by Src Family Tyrosine Protein Kinase
New Investigator Research Grant—$99,993 over two years

North Carolina

David P. Cistola, M.D., Ph.D.
East Carolina University
Greenville, N.C.
Structural Studies of the APP Transmembrane Domain
Investigator-Initiated Research Grant—$240,000 over three years

Carol A. Colton, Ph.D.
Duke University Medical Center
Durham, North Carolina
The Role of Nitric Oxide in the Pathology of Alzheimer’s Disease
Investigator-Initiated Research Grant—$240,000 over three years

Michelle M. Nicolle, Ph.D.
Wake Forest University
Winston-Salem, North Carolina
Muscarinic Receptor Signaling and Cognitive Impairment in Alzheimer’s Disease
Investigator-Initiated Research Grant—$239,952 over three years

Michael Vitek, Ph.D.
Duke University Medical Center
Durham, North Carolina
Novel Therapeutic Reduces Beta-Amyloid Deposition and Alzheimer Pathology
Investigator-Initiated Research Grant—$240,000 over three years

Ohio

Gemma Casadesus Smith, Ph.D.
Case Western Reserve University
Cleveland, Ohio
Aging-Accelerated Mice to Study Mild Cognitive Impairment/Early Alzheimer’s Disease Event Chronology and Therapy
New Investigator Research Grant—$100,000 over two years

Christopher P. Jaroniec, Ph.D.
Ohio State University
Columbus, Ohio
High Resolution NMR Studies of Beta-Amyloid-Congo Red Interaction
New Investigator Research Grant—$100,000 over two years

Chia-Yi Kuan, M.D., Ph.D.
Cincinnati Children's Hospital
Cincinnati, Ohio
Vascular Effects of Amyloid-β Peptide via Rac GTPase in Ischemia-Hypoxia
New Investigator Research Grant—$99,990 over two years

Hyoung-Gon Lee, Ph.D.
Case Western Reserve University
Cleveland, Ohio
A Novel Transgenic Model for Alzheimer’s Disease
New Investigator Research Grant—$100,000 over two years

Chien-Liang G. Lin, Ph.D.
Ohio State University Research Foundation
Columbus, Ohio
Glial Glutamate Transporter EAAT2 as a Potential Therapeutic Target
Investigator-Initiated Research Grant—$240,000 over three years

George Perry, Ph.D.
Case Western Reserve University
Cleveland, Ohio
Mitochondrial Abnormalities in Alzheimer’s Disease
Zenith Fellows Award—$250,000 over two years

Xiongwei Zhu, Ph.D.
Case Western Reserve University
Cleveland, Ohio
Role of DLP1 in Mitochondrial Dysfunction in Alzheimer’s Disease
Investigator-Initiated Research Grant—$240,000 over three years

Oklahoma

Lazelle E. Benefield, Ph.D.
University of Oklahoma, Health Sciences Center
Oklahoma City, Oklahoma
Distance Family-Care Coordination of Home-Dwelling Persons with Dementia
Investigator-Initiated Research Grant—$193,864 over two years

Kristen H. Sorocco, Ph.D.
University of Oklahoma, Health Sciences Center
Oklahoma City, Oklahoma
Evaluation of an Internet-Based Caregiver Support System in Rural Settings
New Investigator Research Grant—$96,004 over two years

Pennsylvania

Laura N. Gitlin, Ph.D.
Thomas Jefferson University
Philadelphia, Pennsylvania
Health-Related Quality of Life in Individuals with Dementia Living at Home
Investigator-Initiated Research Grant—$240,000 over three years

Jennifer H. Lingler, Ph.D.
University of Pittsburgh
Pittsburgh, Pennsylvania
Making Sense of Mild Cognitive Impairment: An Investigation of Patient and Family Perspectives
New Investigator Research Grant—$100,000 over two years

Domenico Pratico, M.D. 
Temple University
Philadelphia, Pennsylvania
The Functional Role of Lipoxygenase in Normal Aging and Alzheimer's Disease
Zenith Fellows Award—$250,000 over two years

Richard Schulz, Ph.D.
University of Pittsburgh
Pittsburgh, Pennsylvania
Measuring Suffering in Persons with Alzheimer’s Disease
Investigator-Initiated Research Grant–$239,749 over three years

Keith Vosseller, Ph.D.
Drexel University
Philadelphia, Pennsylvania
Post-Translational Synaptic Proteomics and Function in Alzheimer’s Disease
New Investigator Research Grant—$100,000 over two years

Rhode Island

Elena F. Martino, Ph.D.
Brown University
Providence, Rhode Island
Efficacy of qEEG Neurocognitive Training in Early-Stage Alzheimer’s Disease
Investigator-Initiated Research Grant—$239,362 over three years

South Carolina

Melissa A. Moss, Ph.D.
University of South Carolina Research Foundation
Columbia, South Carolina
Characterization of Membrane Compositions that Promote Beta-Amyloid Assembly
New Investigator Research Grant—$100,000 over two years

Tennessee

Craig Lindsley, Ph.D.
Vanderbilt University Medical Center
Nashville, Tennessee
Novel Approaches for the Treatment of Alzheimer’s Disease
Investigator-Initiated Research Grant—$239,933 over three years

Charles R. Sanders, Ph.D.
Vanderbilt University Medical Center
Nashville, Tennessee
Modulation of Beta-Amyloid Production by CD147
Investigator-Initiated Research Grant—$240,000 over three years

Texas

Kelly Dineley, Ph.D.
University of Texas Medical Branch at Galveston
Galveston, Texas
Alpha7 nAChR Protects Against Beta-Amyloid Toxicity In Vivo
Investigator-Initiated Research Grant—$239,581 over three years

Pedro Fernandez-Funez, Ph.D
University of Texas Medical Branch at Galveston
Galveston, Texas
New Genetic Suppressors of Beta-Amyloid Neurotoxicity
New Investigator Research Grant—$100,000 over two years

Robia G. Pautler, Ph.D.
Baylor College of Medicine
Houston, Texas
Neuroimaging Assessment of the Role of GM2 in Alzheimer’s Disease
New Investigator Research Grant—$99,400 over two years

Meharvan Singh, Ph.D.
University of North Texas Health Science Center at Fort Worth
Fort Worth, Texas
Progestin-Regulated Neurotrophin Synthesis and Release in Neuroprotection
Investigator-Initiated Research Grant—$240,000 over three years

Utah

Gang Liu, Ph.D.
University of Utah
Salt Lake City, Utah
Developing Nanoparticulated Iron Chelators to Deplete Brain Excess Metals
Investigator-Initiated Research Grant—$240,000 over three years

Virginia

George S. Bloom, Ph.D.
University of Virginia
Charlottesville, Virginia
Signaling from Beta-Amyloid Through Tau in Alzheimer’s Disease
Investigator-Initiated Research Grant—$240,000 over three years

Karen A. Roberto, Ph.D.
Virginia Polytechnic Institute and State University
Blacksburg, Virginia
Understanding Mild Cognitive Impairment: Family Dynamics and Diversity
Investigator-Initiated Research Grant—$240,000 over three years

Washington

Jesse Wiley, Ph.D.
University of Washington
Seattle, Washington
APP Binding-Partner Modulation of Gamma-Secretase-Mediated Proteolysis
New Investigator Research Grant—$100,000 over two years

Wisconsin

Rhonda J. V. Montgomery, Ph.D.
University of Wisconsin-Milwaukee
Milwaukee, Wisconsin
Assessing a Protocol to Strategically Support Family Caregivers
Investigator-Initiated Research Grant—$239,999 over three years